A CASE REPORT OF RARE HEPATOSPLENIC T-CELL LYMPHOMA IN AN ADOLESCENT
Abstract
Hepatosplenic T-cell lymphoma is a rare neoplasm that commonly originates from a subset of T lymphocytes expressing γδ T-cell receptors. It is characteristic for young adult men. Clinical presentation usually includes massive enlargement of liver and spleen, typically without involvement of lymph nodes. Bone marrow is often affected in advanced stage of a disease. Clinical course can be progressive and in most cases prognosis is poor.
Although splenectomy is not obligatory diagnostic and therapeutic procedure in this case it was a way to establishing diagnosis, accompanied with immunophenotipization of bone marrow cells. Combination of intensive chemotherapy and allogenic bone marrow transplantation lead to stabile remission.
References
Falchook GS, Vega F, Dang NH, Samaniego F, Rodrigues MA, Champlin RE, et al. Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment. Ann Oncol 2009;20(6):1080-85. [CrossRef] [PubMed]
Ferreri AJ, Govi S, Pileri S. Hepatosplenic gamma-delta T-cell lymphoma. Crit Rev Oncol Hematol 2012; 83(2):283-92. [CrossRef] [PubMed]
Link MP, Weinstein HJ. Malignant Non Hodgkin lym-phoma in children. In: Pizzo PA, Poplack DG. (eds) Principles and practice of pediatric oncology. Phila-delphia: Lippincot Wiliams&Wilkins, 2006:722-50.
McKinney M, Moffitt AB, Gaulard P, Travert M, De Leval L, Nicolae A, et al. The genetic basis of hepato-splenic T-cell lymphoma. Cancer Discov 2017;7(4): 369-79. [CrossRef] [PubMed]
Pro B, Allen P, Behdad A. Hepatosplenic T-cell lym-phoma: a rare but challenging entity. Blood 2020; 136(18):2018-26. [CrossRef] [PubMed]
Rashidi A, Cashen AF. Outcomes of allogenic stem cell transplantation in hepatosplenic T-cell lymphoma. Blood Cancer J 2015;5(6):e318. [CrossRef] [PubMed]
Van Arnam JS, Lim MS, Elenitoba-Johnson KSJ. Novel insight into the pathogenesis of T-cell lymphomas. Blood 2018;131(21):2320-30. [CrossRef] [PubMed]
Vega F, Medeiros LJ, Bueso-Ramos C, Jones D, Lai R, Luthra R, et al. Hepatosplenic gamma/delta lym-phoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features. Am J Clin Patol 2001; 116(3):410-19. [CrossRef] [PubMed]
Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008;26(25):4124-30. [CrossRef] [PubMed]
Yabe M, Medeirod LJ, Daneshbod Y, Davanlou M, Bueso-Ramos CE, Moran EJ, et al. Hepatosplenic T-cell lymphoma arising in patients with immunodysregu-latory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review. Ann Diagn Pathol 2017;26:16-22. [CrossRef] [PubMed]
Yabe M, Miranda RN, Medeiros LJ. Hepatosplenic T-cell lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors. Hum Pathol 2018;74:5-16. [CrossRef] [PubMed]